Patient holding a pre-filled pen of Semaglutide medication. Marketed as Ozempic, this is a GLP-1 analogue used to treat diabetes. It binds to the GLP-1 receptor and increases insulin secretion, suppresses glucagon secretion as well as slowing gastric emptying. Ozempic is administered by injection into the abdomen (seen here), thigh or upper arm. | |
Licence : | Droits gérés |
Crédit: | Science Photo Library / Marazzi, Dr. P. |
Taille de l’image : | 6048 px × 4024 px |
Model Release : | Disponible |
Property Release : | Non requis |
Restrictions : |
|